Research and Development

Multi Packaging Solutions (“MPS”), a global leader in value-added print and packaging solutions for the pharmaceutical, healthcare and FMCG sectors, …

Sanofi has announced the appointment of Dr Frank Nestle as both the global head of immunology and inflammation research therapeutic …

Eli Lilly has announced that Dr Levi Garraway will join the company as its senior vice president, Global Development & …

Allergan has agreed to buy clinical-stage biotech Vitae Pharmaceuticals for $639 million, or $21 a share – more than double …

Originally published in the September issue of Pharmafocus, Paul Ranson of global law firm Morgan Lewis’ London Life Sciences Practice …

Following the controversy of Mylan’s price increases to its EpiPen (epinephrine) auto-injector, the company’s CEO Heather Bresch is due to …

GlaxoSmithKline’s shingles vaccine Shingrix has topped rival MSD treatment Zostavax as it is shown to remain effective in elderly patients …

The European Commission has approved the use of Eisai’s Kisplyx (lenvatinib) for the treatment of renal cell carcinoma (RCC) following …

Sanofi has announced new Phase III data for its IGlarLixi combination drug for the treatment of diabetes, showing it could …

Bayer has taken yet another step in its dedicated efforts to acquire Monsanto as it raises its offer to $129 …

Roche has announced new results from the Phase III studies of investigational medicine Ocrevus (ocrelizumab) studying relapsing multiple sclerosis (RMS) …

Takeda Pharmaceuticals is reportedly willing to spend as much as $15 billion on acquisitions in the US in efforts to …

Novartis was one of the co-leaders in the $17million series A financing of Irish startup in the development of chronic …

Clinical research organisation ClinTec has announced the expansion of its US management team with the selection of Rick Farris as …

Eisai has revealed new data on long-term seizure control in different seizure types at the 12th European Congress on Epileptology …